Fenwal amicus apheresis reagents and consumables
Ended Purchase Order Awarded Last action
- Contract number
- HT941025PE004
- Awardee
-
Fenwal, Inc. UEI E9UHXHZCGJV5
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $48,356
Award facts
- Contract value 100% obligated
- $48,356.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Japan
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $48,356 | |
| Original award | $0 |
About this award
The Defense Health Agency awarded a $48,356.27 firm fixed-price purchase order to Fenwal, Inc. for FENWAL AMICUS Apheresis Reagents and Consumables, with an ultimate completion date of September 30, 2026. This contract, which was not issued under any set-aside designation, reflects the agency's procurement of specialized apheresis equipment consumables to support military medical operations and blood banking capabilities. Fenwal, Inc., a subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, is a global blood technology company with extensive federal contracting experience since 2007, supplying critical blood collection, separation, storage, and transfusion products to the Department of Defense and other federal health agencies.
The contract performance will occur in Japan and represents Fenwal's continued role as a primary supplier of apheresis-related consumables to federal health operations. The AMICUS apheresis system is a specialized medical device used for automated collection of blood components, and this purchase order ensures the Defense Health Agency maintains adequate supplies of associated reagents and consumables to support transfusion medicine and cell therapy operations across military medical facilities. As a specialized equipment supplier without commercial competition, Fenwal's firm fixed-price arrangement reflects the unique nature of these medical consumables and the company's established position within the federal medical supply chain.
Quick answers
Who was awarded contract HT941025PE004?
HT941025PE004 was awarded to Fenwal, Inc. by Defense Health Agency (Department of Defense) on October 1, 2025.
How much is contract HT941025PE004 worth?
The government has obligated $48,356 on HT941025PE004.
Was contract HT941025PE004 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award